← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2006Last known activity
Oct 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 19 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT07174297CollaboratorPhase 3Oct 30, 2025
- NCT07088146Sponsor investigatorPhase 4Jul 20, 2025
- NCT07088146OfficialPhase 4Jul 20, 2025
- NCT07088146Lead sponsorPhase 4Jul 20, 2025
- NCT07078786CollaboratorPhase 4Jul 13, 2025
- NCT07078786Sponsor investigatorPhase 4Jul 13, 2025
- NCT07078786Lead sponsorPhase 4Jul 13, 2025
- NCT06339294Lead sponsorPhase 1Jun 16, 2023
- NCT06339294OfficialPhase 1Jun 16, 2023
- NCT06343493OfficialN/AJun 16, 2023
- NCT06339294Sponsor investigatorPhase 1Jun 16, 2023
- NCT06343493Sponsor investigatorN/AJun 16, 2023
- NCT06343493Lead sponsorN/AJun 16, 2023
- NCT06446323Lead sponsorN/AMar 1, 2023
- NCT06446323Sponsor investigatorN/AMar 1, 2023
Details
- Last known activity
- Oct 30, 2025